A primer on measures of treatment effectiveness and diagnostic test performance

Wisconsin Medical Journal

Volumn 98, Issue 2, 1999, Pages 37-43

  Katz, David A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DATA BASE; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; MEDICAL DECISION MAKING; PREDICTION; REVIEW; TASK PERFORMANCE; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; LIKELIHOOD FUNCTIONS; RISK; SENSITIVITY AND SPECIFICITY; THERAPEUTICS;

EID: 0032907805     PISSN: 00436542     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Shepard J, Cobbe S, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333:1301-7.
2. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-9.
3. Sacks F, MA MP, Moye L, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Event Trial investigators. N Engl J Med 1996; 335:1001-9.
4. Downs J, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279:1615-22.
5. Laupacis A, Sackett D, Roberts R. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318:1728-33.
6. Malenka D, Baron J, Johansen S, Wahrenberger J, Ross J. The framing effect of relative and absolute risk. J Gen Intern Med 1993, 8:543-8.
7. Rembold C. Number need to screen: Development of a statistic for disease screening. BMJ 1998, 317:307-12.
8. Chatellier G, Zapletal E, Lemaitre D, menard J, Degoulet P. The number needed to treat: A clinically useful nomogram in its proper context. BMJ 1996; 312:426-9.
9. McQuay H, Moore R. Using numerical results form systematic reviews in clinical practice. Ann Intern Med 1997; 126:712-20.
10. Sackett D, Richardson W, Rosenberg W, Haynes R. Evidence-based medicine: How to Practice and Teach EBM. New York: Churchill Livingstone, 1997
11. Lau J, Antman E, Jiminez-Silva J, Kupelnick B, Mosteller F, Chalmers T. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327:248-54.
12. Selker H, Griffith J, D'Agostino R. A time-insensitive predictive instrument for acute myocardial infarction mortality: A multicenter study. Med Care 1991; 29:1196-1211.
13. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary bypass fraft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344:563-70.
14. Glantz S. Primer of biostatistics. New York: McGraw Hill, 1987.
15. Cebul R, Beck L. Teaching clinical decision making. New York: Praeger, 1985.
16. Bravo E, Tarazi R, Dustin H, et al. The changing clinical spectrum of primary aldosteronism. Am J Med 1983; 74:641-51.
17. Ahlquist D, Wieand H, Moertel C, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and HemoQuant tests. JAMA 1993; 269:1262-7.
18. Sershon P, Barry M, Oesterling J. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer. Eur Urol 1994; 25:281-7.
19. Sox H, Blatt M, Higgins M, Marton K. Medical Decision Making. Boston Butterworths, 1988.